Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-19-000008

Exec. Vice Chairman/CEO/Pres. acquired 325,065 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · Exec. Vice Chairman/CEO/Pres.

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2019-02-27 Option exercise : show line 1 in the form +65 65 D
2019-02-27 Option exercise : show line 2 in the form +325,000 325,000 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-02-27 Option exercise : show line 3 in the form Subr Rights(to buy) +65 $1,000.00 $65,000 0 D
Loading xslF345X03/primary_doc.xml…